39 results on '"Goodman, Kirsteen"'
Search Results
2. Commentary on my personal experience of patient and public involvement in the TOPSY trial
3. Clinical effectiveness of vaginal pessary self-management vs clinic-based care for pelvic organ prolapse (TOPSY): a randomised controlled superiority trial
4. Theoretical and practical development of the TOPSY self-management intervention for women who use a vaginal pessary for pelvic organ prolapse
5. Clinical and cost‐effectiveness of pessary self‐management versus clinic-based care for pelvic organ prolapse in women: the TOPSY RCT with process evaluation.
6. Clinical and cost-effectiveness of vaginal pessary self-management compared to clinic-based care for pelvic organ prolapse: protocol for the TOPSY randomised controlled trial
7. The TOPSY pessary self-management intervention for pelvic organ prolapse: a study protocol for the process evaluation
8. Using systematic data categorisation to quantify the types of data collected in clinical trials: the DataCat project
9. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy
10. Clinical and cost-effectiveness of vaginal pessary self-management compared to clinic-based care for pelvic organ prolapse: protocol for the TOPSY randomised controlled trial.:Protocol for the TOPSY randomised controlled trial
11. Patient-Reported Outcomes in Rheumatoid Arthritis: Assessing the Equivalence of Electronic and Paper Data Collection
12. Clinical trial management: a profession in crisis?
13. Characteristics of early Paget's disease in SQSTMI mutation carriers:baseline analysis of the ZIPP study cohort
14. It is unprecedented: trial management during the COVID-19 pandemic and beyond
15. Characteristics of Early Paget's Disease inSQSTM1Mutation Carriers: Baseline Analysis of theZiPPStudy Cohort
16. Where do we go from here? - Opportunities and barriers to the career development of Trial Managers: a survey of UK-based trial management professionals
17. Where do we go from here? - Opportunities and barriers to the career development of Trial Managers: a survey of UK-based trial management professionals
18. Aortic Wall Inflammation Predicts Abdominal Aortic Aneurysm Expansion, Rupture, and Need for Surgical Repair
19. Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM-mediated Paget’s disease of bone
20. Development of a standardised set of metrics for monitoring site performance in multicentre randomised trials: a Delphi study
21. Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to preventSQSTM1-mediated Paget’s disease of bone
22. Abdominal massage plus advice, compared with advice only, for neurogenic bowel dysfunction in MS: a RCT
23. Long term randomised trial of Intensive versus Symptomatic Management in Paget’s Disease of Bone: The PRISM-EZ study
24. Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort.
25. Where do we go from here? - Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals.
26. Symptoms of bowel dysfunction in people with muliple sclerosis
27. Abdominal massage for neurogenic bowel dysfunction in people with multiple sclerosis (AMBER — Abdominal Massage for Bowel Dysfunction Effectiveness Research): study protocol for a randomised controlled trial
28. Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease
29. MRI using ultrasmall superparamagnetic particles of iron oxide in patients under surveillance for abdominal aortic aneurysms to predict rupture or surgical repair: MRI for abdominal aortic aneurysms to predict rupture or surgery—the MA3RS study
30. Common susceptibility alleles andSQSTM1mutations predict disease extent and severity in a multinational study of patients with Paget's disease
31. Long-term effects of symptomatic vs intensive bisphosphonate therapy for Paget's disease of bone: the PRISM-EZ study
32. Relation between circulation measles virus antibodies and disease severity in Paget's disease: The prism study
33. Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone
34. MRI using ultrasmall superparamagnetic particles of iron oxide in patients under surveillance for abdominal aortic aneurysms to predict rupture or surgical repair: MRI for abdominal aortic aneurysms to predict rupture or surgery-the MA3RS study
35. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone.
36. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone
37. Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1 -mediated Paget's disease of bone.
38. Long-Term Randomized Trial of Intensive Versus Symptomatic Management in Paget's Disease of Bone: The PRISM-EZ Study.
39. Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.